Wheadon David E.
SEC CIK 1789507 · EDGAR
BoughtSold
Most active insiders at SHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| 2 | Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| 3 | Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| 4 | GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| 5 | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| 6 | GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| 7 | WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| 8 | GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| 9 | Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| 10 | Rutz Michael P | Pres of Sterigenics | — | $2.83M |
| 14 | Wheadon David E. | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 17:19 | 2026-05-22 | SHC | Sotera Health Co | Wheadon David E. | Dir | A - Grant | $0.00 | +15.0K | 89.9K | +20% | $0 | |
| 2026-05-14 16:06 | 2026-05-13 | INDV | Indivior Pharmaceuticals, Inc. | Wheadon David E. | Dir | A - Grant | $0.00 | +10.4K | 30.8K | +51% | $0 | |
| 2026-01-28 | 2026-01-26 | INDV | Indivior Pharmaceuticals, Inc. | Wheadon David E. | Dir | A - Grant | $0.00 | +5,955 | 20.4K | +41% | $0 | |
| 2026-01-07 | 2026-01-05 | INDV | Indivior Pharmaceuticals, Inc. | Wheadon David E. | Dir | P - Purchase | $35.39 | +1,771 | 14.4K | +14% | +$62.7K | |
| 2025-05-27 | 2025-05-22 | SHC | Sotera Health Co | Wheadon David E. | Dir | A - Grant | $0.00 | +19.1K | 74.9K | +34% | $0 | |
| 2024-05-29 | 2024-05-24 | SHC | Sotera Health Co | Wheadon David E. | Dir | A - Grant | $0.00 | +20.1K | 55.8K | +56% | $0 | |
| 2023-05-31 | 2023-05-26 | SHC | Sotera Health Co | Wheadon David E. | Dir | A - Grant | $0.00 | +15.7K | 35.7K | +79% | $0 | |
| 2022-05-31 | 2022-05-27 | SHC | Sotera Health Co | Wheadon David E. | Dir | A - Grant | $0.00 | +10.6K | 20.0K | +114% | $0 |
Purchase Sale Sale after option exercise All abbreviations